-Reuters
Citigroup Maintains Neutral on Nu Skin Enterprises, Raises Price Target to $41
Citigroup analyst Chasen Bender maintains Nu Skin Enterprises (NYSE:NUS) with a Neutral and raises the price target from $35 to $41.
Related Posts
Agenus Inc Reveals Colorectal Cancer Treatment Results with BOT/BAL in NEST-1 Study
Agenus Inc. (NASDAQ:AGEN), a leader in developing immunological cancer treatments, today announced results from the NEST-1 study, an investigator-sponsored trial (IST) evaluating the combination of botensilimab and
Generac Hldgs Q2 EPS $2.99 Beats $2.63 Estimate, Sales $1.29B Beat $1.27B Estimate
Generac Hldgs (NYSE:GNRC) reported quarterly earnings of $2.99 per share which beat the analyst consensus estimate of $2.63 by 13.69 percent. This is a 25.1 percent increase over earnings of $2.39 per share from the same
Yotta Acquisition Corporation Announces Extension Of Combination Period And Additional Contribution To Trust Account To Extend Combination Period
Yotta Acquisition Corporation (NASDAQ:YOTA, the "Company")))), a special purpose acquisition company, announced today that that at its special meeting of stockholders on April 19, 2023 (the "Meeting"), the Company's